Relationship between Programmed Cell Death Protein Ligand 1 Expression and Immune-related Adverse Events in Non-small-cell Lung Cancer Patients Treated with Pembrolizumab
2017 ◽
Vol 22
◽
pp. 113-113
W. Nie
◽
M.-D. Xu
◽
L. Gan
◽
Y. Zhang
◽
B.-H. Han
Luca Cantini
◽
Federica Pecci
◽
Floris Dammeijer
◽
Joachim G.J.V. Aerts
◽
Rossana Berardi
2017 ◽
Vol 18
(5)
◽
pp. 572-582.e1
◽
Kazuki Takada
◽
Gouji Toyokawa
◽
Tatsuro Okamoto
◽
Mototsugu Shimokawa
◽
Yuka Kozuma
◽
...
2017 ◽
Vol 8
(37)
◽
pp. 61618-61625
◽
Hidenobu Ishii
◽
Koichi Azuma
◽
Akihiko Kawahara
◽
Norikazu Matsuo
◽
Takaaki Tokito
◽
...
2018 ◽
Vol 30
(4)
◽
pp. 125-131
◽
Dina M. El-Guindy
◽
Duaa S. Helal
◽
Nesreen M. Sabry
◽
Mohamed Abo El-Nasr
2020 ◽
Vol 25
◽
pp. 100249
Takehiro Tozuka
◽
Noriko Yanagitani
◽
Hiroaki Sakamoto
◽
Hiroshi Yoshida
◽
Yoshiaki Amino
◽
...
Xiaoying Sun
◽
Raheleh Roudi
◽
Ting Dai
◽
Shangya Chen
◽
Bin Fan
◽
...
2017 ◽
Vol 8
(4)
◽
pp. 320
◽
Carmelo Tibaldi
◽
Alice Lunghi
◽
Editta Baldini
Narjust Duma
◽
Azzouqa Abdel‐Ghani
◽
Siddhartha Yadav
◽
Katherine P. Hoversten
◽
Clay T. Reed
◽
...
Close
Export Citation Format
Close
Share Document
Close